238 related articles for article (PubMed ID: 26141367)
1. Deficiency of sorting nexin 10 prevents bone erosion in collagen-induced mouse arthritis through promoting NFATc1 degradation.
Zhou C; You Y; Shen W; Zhu YZ; Peng J; Feng HT; Wang Y; Li D; Shao WW; Li CX; Li WZ; Xu J; Shen X
Ann Rheum Dis; 2016 Jun; 75(6):1211-8. PubMed ID: 26141367
[TBL] [Abstract][Full Text] [Related]
2. SNX10 Plays a Critical Role in MMP9 Secretion via JNK-p38-ERK Signaling Pathway.
Zhou C; Wang Y; Peng J; Li C; Liu P; Shen X
J Cell Biochem; 2017 Dec; 118(12):4664-4671. PubMed ID: 28498635
[TBL] [Abstract][Full Text] [Related]
3. SNX10 is required for osteoclast formation and resorption activity.
Zhu CH; Morse LR; Battaglino RA
J Cell Biochem; 2012 May; 113(5):1608-15. PubMed ID: 22174188
[TBL] [Abstract][Full Text] [Related]
4. Loss of SH3 domain-binding protein 2 function suppresses bone destruction in tumor necrosis factor-driven and collagen-induced arthritis in mice.
Mukai T; Gallant R; Ishida S; Kittaka M; Yoshitaka T; Fox DA; Morita Y; Nishida K; Rottapel R; Ueki Y
Arthritis Rheumatol; 2015 Mar; 67(3):656-67. PubMed ID: 25470448
[TBL] [Abstract][Full Text] [Related]
5. 6-O-angeloylplenolin inhibits osteoclastogenesis in vitro via suppressing c-Src/NF-κB/NFATc1 pathways and ameliorates bone resorption in collagen-induced arthritis mouse model.
Li ZC; Li M; Xiao LX; Zheng X; Li R; Dong SJ; Wang Y; Wen HY; Ruan KL; Cheng KG; Chen M; Tan YH
Biochem Pharmacol; 2024 Jun; 224():116230. PubMed ID: 38643905
[TBL] [Abstract][Full Text] [Related]
6. Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis.
Sims NA; Green JR; Glatt M; Schlict S; Martin TJ; Gillespie MT; Romas E
Arthritis Rheum; 2004 Jul; 50(7):2338-46. PubMed ID: 15248235
[TBL] [Abstract][Full Text] [Related]
7. Total Saponin from Anemone flaccida Fr. Schmidt Prevents Bone Destruction in Experimental Rheumatoid Arthritis via Inhibiting Osteoclastogenesis.
Liu C; Yang Y; Sun D; Wang C; Wang H; Jia S; Liu L; Lin N
Rejuvenation Res; 2015 Dec; 18(6):528-42. PubMed ID: 26418168
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid Receptor 2 Agonist Prevents Local and Systemic Inflammatory Bone Destruction in Rheumatoid Arthritis.
Zhu M; Yu B; Bai J; Wang X; Guo X; Liu Y; Lin J; Hu S; Zhang W; Tao Y; Hu C; Yang H; Xu Y; Geng D
J Bone Miner Res; 2019 Apr; 34(4):739-751. PubMed ID: 30508319
[TBL] [Abstract][Full Text] [Related]
9. Tetrandrine attenuates the bone erosion in collagen-induced arthritis rats by inhibiting osteoclastogenesis via spleen tyrosine kinase.
Jia Y; Miao Y; Yue M; Shu M; Wei Z; Dai Y
FASEB J; 2018 Jun; 32(6):3398-3410. PubMed ID: 29401630
[TBL] [Abstract][Full Text] [Related]
10. Impaired signaling through the Fms-like tyrosine kinase 3 receptor increases osteoclast formation and bone damage in arthritis.
Svensson MN; Erlandsson MC; Jonsson IM; Andersson KM; Bokarewa MI
J Leukoc Biol; 2016 Mar; 99(3):413-23. PubMed ID: 26392589
[TBL] [Abstract][Full Text] [Related]
11. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the receptor tyrosine kinase Tyro3 inhibits synovial hyperplasia and bone damage in arthritis.
Ruiz-Heiland G; Zhao Y; Derer A; Braun T; Engelke K; Neumann E; Mueller-Ladner U; Liu Y; Zwerina J; Schett G
Ann Rheum Dis; 2014 Apr; 73(4):771-9. PubMed ID: 23632195
[TBL] [Abstract][Full Text] [Related]
13. Adipose-Derived Mesenchymal Stem Cells Prevent Systemic Bone Loss in Collagen-Induced Arthritis.
Garimella MG; Kour S; Piprode V; Mittal M; Kumar A; Rani L; Pote ST; Mishra GC; Chattopadhyay N; Wani MR
J Immunol; 2015 Dec; 195(11):5136-48. PubMed ID: 26538398
[TBL] [Abstract][Full Text] [Related]
14. Activation of the Peroxisome Proliferator-Activated Receptor γ Coactivator 1β/NFATc1 Pathway in Circulating Osteoclast Precursors Associated With Bone Destruction in Rheumatoid Arthritis.
Ma JD; Jing J; Wang JW; Mo YQ; Li QH; Lin JZ; Chen LF; Shao L; Miossec P; Dai L
Arthritis Rheumatol; 2019 Aug; 71(8):1252-1264. PubMed ID: 30802366
[TBL] [Abstract][Full Text] [Related]
15. Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis.
Ledesma-Colunga MG; Adán N; Ortiz G; Solís-Gutiérrez M; López-Barrera F; Martínez de la Escalera G; Clapp C
Arthritis Res Ther; 2017 May; 19(1):93. PubMed ID: 28506283
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kappaB activation.
Hirayama T; Dai S; Abbas S; Yamanaka Y; Abu-Amer Y
Arthritis Rheum; 2005 Sep; 52(9):2719-29. PubMed ID: 16142755
[TBL] [Abstract][Full Text] [Related]
17. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
18. Snx10 and PIKfyve are required for lysosome formation in osteoclasts.
Sultana F; Morse LR; Picotto G; Liu W; Jha PK; Odgren PR; Battaglino RA
J Cell Biochem; 2020 Apr; 121(4):2927-2937. PubMed ID: 31692073
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
20. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
